Tenecteplase indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Tenecteplase}} {{CMG}}; {{AE}} {{SS}} ==Indications And Usage== TNKase® (Tenecteplase) is indicated for use in the reduction of mortality associated with acute [...")
 
m (Protected "Tenecteplase indications and usage": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Tenecteplase#Adult Indications and Dosage]]
{{Tenecteplase}}
{{CMG}}; {{AE}} {{SS}}


==Indications And Usage==
[[Category: Cardiovascular Drugs]]
TNKase® (Tenecteplase) is indicated for use in the reduction of mortality associated with acute [[myocardial infarction]] ([[AMI]]). Treatment should be initiated as soon as possible after the onset of [[AMI]] symptoms<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TNKASE (TENECTEPLASE) KIT [GENENTECH, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=69e391bf-1250-4083-aa60-6aa41c33657f | publisher =  | date =  | accessdate = 6 February 2014 }}</ref>
[[Category: Drug]]
 
==References==
 
{{Reflist|2}}
 
[[Category:Thrombolytic drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 17:13, 20 August 2015